TNXP

Tonix Pharmaceuticals Holding Corp.

Healthcare · Biotechnology

$152.64 sample

+1.41 (+0.93%) 1D

Market cap

$972.6B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-01

Alerts

8

Price$152.64 +21.48% 3M daily closessample

153.12125.65

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: Chief Financial Officer
Sep 17INSInsider sell: Director
Sep 10INSInsider buy: General Counsel
Sep 01SECDEF 14A filed
Aug 26INSInsider sell: Chief Executive Officer
Aug 21INSInsider buy: 10% owner
Aug 13INSInsider sell: Director
Aug 05SECForm 144 filed

Sign up to see the real TNXP record →

Company facts

SEC EDGAR registration

Name: Tonix Pharmaceuticals Holding Corp.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: 0sample, -100 to +100
Reporting currency: USD

Who is positioning in TNXP

sample

Insiders: 11 insider transactions over 90 days, net selling, $22.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 41 funds hold $21.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$36.4B +14.1% y/y

Q4 2024Q3 2026

Inventory$23.2B +17.7% y/y

Q4 2024Q3 2026

Accounts receivable$16.0B +11.2% y/y

Q4 2024Q3 2026

Total debt$42.7B +6.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $750.0B +5.6% 3M
Sample peer B: $155.7B -6.7% 3M
Sample peer C: $318.4B -6.6% 3M
Sample peer D: $945.4B +4.1% 3M
Sample peer E: $370.7B +6.8% 3M